| Financial Year |
March 31 2023 |
| Monetary Funds |
277,992,725.58 |
| Held-for-trading Financial Assets |
5,000.00 |
| Notes Receivable |
498,070.89 |
| Accounts Receivable |
418,967,107.89 |
| Advances to Suppliers |
118,148,156.20 |
| Other Receivables |
163,950,251.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
230,771,497.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
117,898,468.42 |
| Other Current Assets |
46,496,809.13 |
| Total Current Assets |
1,951,834,727.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
478,173,590.00 |
| Long-term Equity Investment |
242,586,227.92 |
| Investment Properties |
3,240,405.07 |
| Fixed Assetes |
208,098,823.54 |
| Under-construction Projects |
14,737,514.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
55,466,017.90 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,652,848.24 |
| R&D expenses |
-- |
| Goodwill |
5,564,463.84 |
| Long-Term Deferred and Prepaid Expenses |
4,956,311.13 |
| Deferred Income Tax Assets |
92,685,320.30 |
| Other Non-Current Assets |
351,283,268.04 |
| Sub-Total of Non-Current Assets |
1,698,975,836.87 |
| Total Assets |
3,650,810,564.61 |
| Short-Term Loans |
148,802,614.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
54,900,000.00 |
| Accounts Payable |
563,717,420.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,995,022.26 |
| Taxes Payable |
749,759.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
90,536,288.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
77,232,998.34 |
| Other Current Liabilities |
59,558,311.42 |
| Sub-Total of Current Liabilities |
1,105,433,815.47 |
| Long-term Loans |
808,911,913.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
186,177,146.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
195,573.50 |
| Other Non-Current Liabilities |
33,587,590.29 |
| Sub-Total of Non-Current Liabilities |
1,187,454,900.00 |
| Total Liabilities |
2,292,888,715.47 |
| Paid-In Capital(Or Share Stock) |
290,146,240.00 |
| Capital Surplus |
931,903,976.11 |
| Surplus Reserve |
45,177,411.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-183,336,261.69 |
| Minority Stockholder's Interest |
274,030,483.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,083,891,365.58 |
| Owner's Equity（Stockholder's Equity） |
1,357,921,849.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,650,810,564.61 |
